Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJ.M. Tourani, Loı̈c Mourey, V. Servent, Trang Huyen Thi Nguyen, V. Girre, S. Favrel, Marie Claire Pinel, Nicolás Isambert
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Geriatric oncology: an overview of progresses and challenges
10.4143/crt.2010.42.2.61 · 2010
Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment
2008
Superacidic generation of new antitumour agents
2000
Vinflunine, a second generation novel Vinca Alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockers
10.2174/1381612013397456 · 2001
Vinflunine (20′,20′-difluoro-3′,4′-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro
10.1023/a:1006022811895 · 1998
Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine
10.1124/mol.60.1.225 · 2001
Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells
10.1097/00001813-199907000-00005 · 1999
A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity
10.1016/s0026-895x(24)13258-0 · 1998
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen
10.1038/sj.bjc.6603118 · 2006
Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract
10.1200/jco.2008.20.5534 · 2009
Vinflunine
10.2165/11204970-000000000-00000 · 2010
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours
10.1093/annonc/mdg174 · 2003
Phase I study of IV vinflunine given on a weekly schedule in previously untreated patients with advanced solid tumours
2003
Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks
10.1007/s10637-005-3902-0 · 2006
Vinflunine metabolism and disposition in cancer patients
2002
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
10.1002/ijc.25516 · 2010
Pharmacology of anticancer drugs in the elderly population
10.2165/00003088-200342140-00003 · 2003
Unresolved referenced work
Kept as external metadata until matched
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
10.1093/jnci/92.3.205 · 2000
A simple and sensitive high-performance liquid chromatographic method for the determination of vinflunine and 4-O-deacetylvinflunine from human blood
10.1097/ftd.0b013e3181f6010c · 2010
Influence of renal dysfunction on the pharmacokinetic of i.v. vinflunine: results of a phase I trial in cancer patients
2011
Pharmacokinetics and drug metabolism in the elderly
10.1080/03602530902722679 · 2009
Unresolved referenced work
2011
No additional external references are available.